Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas
β Scribed by Hideho Okada; Frank S Lieberman; Kevin A Walter; L Dade Lunsford; Douglas S Kondziolka; Ghassan K Bejjani; Ronald L Hamilton; Alejandro Torres-Trejo; Pawel Kalinski; Quan Cai; Jennifer L Mabold; Howard D Edington; Lisa H Butterfield; Theresa L Whiteside; Douglas M Potter; S Clifford Schold; Ian F Pollack
- Book ID
- 119905477
- Publisher
- BioMed Central
- Year
- 2007
- Tongue
- English
- Weight
- 551 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1479-5876
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Tumor cells transfected to express immunostimulatory cytokines, or admixed with similarly modified bystander cells, are able to induce immune responses against unmodified tumor cells in animal models. For treatment of human patients, a vaccine composed of autologous tumor cells and IL-2-secreting al
## Abstract InterferonβΞ² (IFNβΞ²) has been used as an antitumor drug against human glioma, melanoma and medulloblastoma since the 1980s. Recently, we developed a new gene therapy using the __IFN__βΞ² gene against malignant gliomas and then began clinical trials in 2000. Since stimulation of immune sy